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Objective: To evaluate the antibacterial activity of eight plants against methicillin-
resistant Staphylococcus aureus (MRSA), extended spectrum beta-lactamase and
carbapenemase-resistant Enterobacteriaceae, which are the most prevalent causes of in-
fections in inpatients.
Methods: The antibacterial activity was calculated based on the minimum inhibitory
concentration using Mueller–Hinton broth in a microdilution method.
Results: The best antibacterial activity, calculated as minimum inhibitory concentration
values, against MRSA was shown by the Kaempferia pandurata (Roxb) (K. pandurata)
extract (256 mg/mL) and the Senna alata (S. alata) extract (512 mg/mL). Phytochemical
screening of dried S. alata leaf and its extract showed the presence of ﬂavonoids, alka-
loids, saponins, quinones, tannins and sterols, while dried K. pandurata and its extract
only showed the presence of ﬂavonoids and sterols/triterpenoids.
Conclusions: K. pandurata and S. alata have the potential to be developed as antibac-
terial agents, especially against MRSA strain, but further in vivo research and discovery
of the mode of its action are still needed to shed light on the effects.1. Introduction
Antibiotic resistance has become a serious and widespread
problem in developing countries, both in hospitals and the
community, causing high mortality each year [1]. Inappropriate
usage of antibiotics is the most inﬂuential factor of antibiotic
resistance and the global emergence of multi-drug resistant
bacteria is increasingly limiting the effectiveness of current
drugs and signiﬁcantly causing treatment failure [2]. Antibiotic
resistance results in reduced efﬁcacy of antibacterial drugs,
making the treatment of patients difﬁcult, costly, or even
impossible. The impact on particularly vulnerable patients is
most obvious, resulting in prolonged illness and increased
mortality [3]. New therapy classes of antibiotics have become a
popular choice to reduce antibiotic resistance. However,
antibiotic resistance is difﬁcult to reduce. One strategy to
avoid this is by using alternative therapeutic agents from
plants that are effective against antibiotic resistant bacteria,safe and have low cost. Consequently, one of the objectives of
our research group is to investigate the potential antibacterial
properties of traditional plants. In the present study, we used
eight plants that have the potential to be used as antibacterial
agents against non-resistant bacteria [4–11], to conduct
antibacterial activity assays against resistant bacteria isolated
from inpatients, such as methicillin-resistant Staphylococcus
aureus (S. aureus) (MRSA), extended spectrum beta lactamase
(ESBL)-producing bacteria and carbapenemase-resistant Enter-
obacteriaceae (CRE). The eight plants used in this study were
Curcuma xanthorrhiza (C. xanthorrhiza), Ocimum sanctum
(O. sanctum), Senna alata (S. alata), Kaempferia pandurata
(Roxb) (K. pandurata), Zingiber ofﬁcinale (Z. ofﬁcinale), Mor-
inga oleifera (M. oleifera), Tamarindus indica (T. indica) and
Pangium edule (P. edule).
2. Materials and methods
2.1. Plants
Fresh plant parts were collected from the Manoko ﬁeld in
Bandung at winter season. The collected plants were identiﬁed
and classiﬁed according to the Herbarium Bandungense at thean open access article under the CC BY-NC-ND
Table 1
The extract yield.
Plants Part of plants Solvent Yield (%)
K. pandurata Rhizome Ethanol (96%) 26.43
C. xanthorrhiza Rhizome Ethanol (96%) 22.35
Z. ofﬁcinale Rhizome Ethanol (96%) 13.53
O. sanctum Leaf Ethanol (96%) 6.19
S. alata Leaf Ethanol (96%) 21.66
M. oleifera Leaf Ethanol (96%) 11.12
P. edule Fruit Aqua dest 6.28
T. indica Fruit Aqua dest 63.72
Table 2
The antibacterial activity of eight plants towards MRSA, ESBL and CRE.
Plant extracts MIC (mg/mL)
MRSA ESBL CRE
O. sanctum > 8192 > 8192 > 8192
Z. ofﬁcinale > 8192 > 8192 > 8192
M. oleifera > 8192 > 8192 > 8192
S. alata 512 > 8192 > 8192
K. pandurata 256 4096 > 8192
C. xanthorrhiza 512 > 8192 > 8192
P. edule > 8192 > 8192 > 8192
T. indica > 8192 > 8192 > 8192
Tetracycline HCl 32
Vancomycin HCl 1
Cefotaxime 64 128
Meropenem 0.5 2
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were then dried under sunlight for two days. The dried plants
were then milled into ﬁne powder using a milling machine.
2.2. Materials
The used materials were ninety-six microwell plates, auto-
clave, shaker, laminar air ﬂow, Eppendorf, micropipette, sepa-
ration funnel, glass set, chromatography set and MRSA
collected from hospital, ethanol, n-hexane, ethyl acetate, water,
dimethyl sulfoxide, Mueller–Hinton broth and Mueller–Hinton
agar, curved.
2.3. Preparations of extracts
Dried C. xanthorrhiza, O. sanctum, S. alata, K. pandurata,
Z. ofﬁcinale and M. oleifera were extracted by the reﬂux method
using ethanol 96% while T. indica and P. edule were extracted
by maceration using distilled water (aqua dest). The solvent in
the extracts was completely removed by using a rotary evapo-
rator to obtain a semi-solid mass and the yield was calculated
based on the weight of the dried plants. A portion of the
resulting crude extract was fractioned by a separation funnel
using n-hexane, ethyl acetate, and water as solvents. Eluates
were collected in 1 L Erlenmeyer ﬂasks and each fraction was
subjected to evaporation under reduced pressure in a rotary
evaporator. Fractions were stored at 4 C until assayed.
2.4. Bacterial preparation
The MRSA, ESBL-producing bacteria and CRE were
taken from isolated specimens which exhibited resistance to
some antibiotics in hospitalized patients. They were taken
based on ethical clearance approval from the ethical com-
mittee in the hospital. The bacteria were cultured over night
(18–24 h) at 37 C on nutrient broth for the preparation of cell
suspensions. The bacteria cell suspensions were homogenized
and adjusted to 0.5 McFarland standards (5 × 105 CFU/mL)
using spectrophotometry.
2.5. Antimicrobial susceptibility assays
The minimum inhibitory concentrations (MICs) of plant ex-
tracts were initially determined using Mueller–Hinton broth
microdilution [12]. MIC determination was performed by a serial
dilution technique using 96-well microtiter plates. Plant extract
(100 mL) was placed into the well/plate. Then, 100 mL bacterial
cell suspensions were placed in each well/plate. Microplates
were incubated for 24 h at 37 C. The lowest concentrations
without visible growth completely inhibited the bacteria (MICs).
Dimethyl sulfoxide was used as a control and Mueller–Hinton
broth as negative control. Tetracycline and vancomycin were
used as positive controls for MRSA, while cefotaxime and
meropenem were used as positive controls for ESBL–producing
bacteria and CRE. The assay was repeated twice with three
replicates per assay.
2.6. Phytochemical screening
The selected plants which showed the MIC were screened for
the presence of different classes of secondary metabolites,including alkaloids, ﬂavonoids, alcaloid, saponins, tannins,
quinones and sterols/triterpenes using previously described
methods [13].
3. Results
3.1. Extracts yield
The ethanolic extracts of eight plants and the water extracts
of two plants were calculated for the yield. T. indica showed the
highest yield in water solvent, which showed that its constituents
were relatively polar (Table 1).
3.2. The antibacterial activity
The antibacterial activity of the eight extracts were assayed
in vitro by the agar microdilution method against three resistant
bacteria. The antibacterial activity against each bacterium was
observed to be varied. Table 2 shows that among the eight
plants, K. pandurata exhibited the smallest value of MIC against
MRSA (256 mg/mL) (Figure 1), while S. alata and
C. xanthorrhiza also had the same activity against MRSA
(Figures 2 and 3). This showed that K. pandurata, S. alata and
C. xanthorrhiza had the potential to be developed as antibacte-
rial agents for MRSA strains.
3.3. Phytochemical analysis
The screening of the phytochemical composition was con-
ducted only for the two dried plants, S. alata and K. pandurata,
as well as their extracts, that showed the lowest MIC, because
they have the potential to be developed as antibacterial agents.
The secondary metabolites are shown in Table 3. All tested
Figure 2. MIC value of S. alata against MRSA at 512 mg/mL.
Figure 3. MIC value of C. xanthorrhiza against MRSA at 512 mg/mL.
Figure 1. MIC value of K. pandurata against MRSA at 256 mg/mL.
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K. pandurata, only ﬂavonoids and steroid/triterpenoids were
present.Table 3
Results of phytochemical analysis of dried S. alata and its extracts.
Secondary metabolites S. alata K. pandurata
Dried Extract Dried Extract
Flavonoid + + + +
Quinnon + + – –
Saponin + + – –
Tannin + + – –
Alcaloid + + – –
Steroid/triterpenoid + + + +
+: Present; −: Absent.4. Discussion
The research for new antibacterial agents has become a very
important endeavor, especially in recent times, considering the
escalating levels of antibiotic resistance among pathogenic
bacteria. One of the efforts in this research is focused on the use
of medicinal plants, which are widely available resources, less if
no side effects, less expensive and have shown antimicrobial
properties [14]. Also, the therapeutic properties of medicinal
plants are well recognized at a global level, especially for
antibiotic development. Thus, the research of alternative and
effective medicines from plants against such resistant bacteria
has become an important concern all over the world [15].
Antibiotic misuse has been considered as a major cause of
antibiotic resistant bacteria. As a result, bacteria become
resistant to antibiotics, which are in turn less effective after
extended periods of use. Pharmaceutical companies whose
efforts are focused on the production and manufacture of
antibiotics strive to manufacture new generations of antibiotics
which are capable of treating such antibiotic-resistant bacterial
strains [16].
The evolution of antibiotic-resistant bacteria has left researchers
scrambling to develop new and stronger antibiotics. MRSA,
ESBL-producing bacteria and CRE are commonly occurring drug
resistant bacteria in hospitals. MRSA is a major pathogen causing
nosocomial and community acquired infection throughout theworld. It is also one of the leading causes of skin, soft tissue, bone,
joint, abscess and normal heart valve infections and its infections
in humans have been associated with excess morbidity, mortality
and increased length of hospitalization [14]. ESBL is an enzyme
that mediates resistance to third generation cephalosporins (e.g.,
ceftazidime, cefotaxime and ceftriaxone) and monobactams
(aztreonam), but do not affect cephamycins (cefoxitin and
cefotetan) or carbapenems (meropenem and imipenem).
Escherichia coli, Klebsiella pneumoniae and Klebsiella oxytoca
are the most common ESBL-producing pathogens [17].
The microdilution method was used in the present study
because it is a quantitative reference method routinely used in
clinical laboratories. In this method, susceptibility panels in 96-
well microtiter plates contained various concentrations of anti-
microbial agents. Then, standardized numbers of bacteria were
inoculated into the wells of the microtiter plates and incubated
overnight at 35 C. The MIC value was observed as the lowest
concentration where no viability was observed in the wells after
incubation. Compared with agar-based methods, broth micro-
dilution can decrease much labor and time [18].
Each of the tested extracts displayed antibacterial activity
against MRSA, ESBL-producing bacteria and CRE. Further-
more, all extracts showed highly varying MIC values against
those resistant bacteria, but the lowest MIC value belonged to
S. alata leaf extract (512 mg/mL) and K. pandurata (256 mg/mL)
against MRSA. A previous study has shown that S. alata is
susceptible to Streptococcus pyogenes and S. aureus, and the
ethanolic extract of K. pandurata had antibacterial activity
against MRSA, methicillin-susceptible S. aureus and Salmonella
typhi at varying values of MIC [7]. MRSA has the ability to grow
in the presence of beta-lactams and its derivatives, including
cephalosporin and penicillin. This resistance is intrinsic and can
be transferred to susceptible strains through horizontal transfer
of the mecA gene [16]. All plant extracts showed no antibacterial
activity with their high MIC values against ESBL-producing
bacteria and CRE.
The results obtained from the present study provide evidence
that ethanolic extracts of S. alata and K. pandurata exhibit
antibacterial activities against isolated MRSA strain, which
suggests that they may be clinically useful. Further research in
respect of these ﬁndings are needed and are promising.
Preliminary phytochemical analyses revealed that
K. pandurata only consisted of ﬂavonoids and sterols/triterpe-
noids while S. alata contained ﬂavonoids, alkaloids, saponins,
tannins, quinones, and sterols/triterpenoids. These bioactive
compounds have been reported to be used by plants for pro-
tection against bacterial and are responsible for antimicrobal
activity [7,19,20].
K. pandurata and S. alata were shown to be potentially
developed as antibacterial agents, especially for MRSA strain.
Further in vivo research and discovery of mode action are
needed to shed light on their antibacterial effects.
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